Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Cardiotoxicity Brana I; Tabernero JAnn Oncol 2010[Oct]; 21 Suppl 7 (ä): vii173-9Cancer treatment has improved extraordinarily in recent years. The development of targeted therapies has widened the cardiotoxic spectrum of antineoplastic drugs. Optimum management of cardiovascular disease before and during antineoplastic treatment is essential to reduce morbidity and mortality in cancer patients. This article reviews the incidence and characteristics of cardiotoxic effects of antineoplastic drugs with special focus on the pathophysiological mechanisms. It also emphasizes the importance of early detection and correction of cardiovascular risk factors and the relevance of close cardiac monitoring during antineoplastic treatment in order to reduce cardiotoxicity.|Antineoplastic Agents/*adverse effects[MESH]|Arrhythmias, Cardiac/chemically induced/drug therapy/physiopathology/prevention & control[MESH]|Cardiovascular Agents/therapeutic use[MESH]|Heart Diseases/*chemically induced/epidemiology/prevention & control[MESH]|Humans[MESH]|Incidence[MESH]|Ischemia/chemically induced/complications/drug therapy/prevention & control[MESH]|Molecular Targeted Therapy/methods[MESH]|Neoplasms/drug therapy/epidemiology[MESH]|Ventricular Dysfunction, Left/chemically induced/drug therapy/prevention & control[MESH] |